Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure

Rajinikanth Gogiraju1,2,3,4, Magdalena L Bochenek2,3,4, Katrin Schäfer1,2,3,4

  • 1Center for Cardiology, Cardiology I, Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany.

Insights

Cardiac hypertrophy impairs blood vessel growth, leading to heart failure. This review explores how endothelial cells, angiogenesis regulators, and cellular stress contribute to vascular dysfunction and heart disease progression.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Pathophysiology

Background:

  • Endothelial cells are crucial for heart function and disease.
  • Reduced cardiac capillary density leads to hypoxia, cell death, and fibrosis, contributing to heart failure.
  • Molecular mechanisms of inadequate cardiac vascularization during pathological hypertrophy are not fully understood.

Purpose of the Study:

  • To review vascular changes during cardiac hypertrophy and transition to heart failure.
  • To summarize findings on factors regulating cardiac angiogenesis in preclinical models.
  • To discuss signaling pathways in endothelial cells and their disruption by stress.

Main Methods:

  • Review of preclinical models (transgenic mice, experimental hypertrophy).
  • Analysis of paracrine regulation of cardiac angiogenesis by various cell types.
  • Discussion of signaling events in endothelial cells, including negative regulators.

Main Results:

  • Identified factors from cardiomyocytes, pericytes, and inflammatory cells influencing angiogenesis.
  • Highlighted roles of protein tyrosine phosphatase-1B and tumor suppressor p53 in angiogenesis regulation.
  • Discussed how hypoxia and oxidative stress disrupt angiogenic signaling in endothelial cells.

Conclusions:

  • Endothelial cell dysfunction, including death and myofibroblast-like conversion, contributes to cardiac fibrosis and heart failure.
  • Dysfunctional endothelial cells secrete factors that negatively impact cardiomyocytes, exacerbating heart remodeling.
  • Reciprocal interactions between endothelial cells and cardiomyocytes form a vicious cycle in pathological hypertrophy.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
313